ロード中...
Genetic methylation and lymphoid malignancies: biomarkers of tumor progression and targeted therapy
Lymphoid malignancies, mainly including lymphocytic leukemia and lymphoma, are a group of heterogeneous diseases. Although the clinical outcome of patients has been significantly improved with current immuno-chemotherapy, definitive biomarkers remain to be investigated, particularly those reflecting...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4101819/ https://ncbi.nlm.nih.gov/pubmed/24252620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-7771-1-24 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|